Media, investors, advocacy organizations and others, please contact us here.

Patients With Newly Diagnosed IgAN Demonstrated Stable eGFR With First-Line Sparsentan Over Two Years in the SPARTAN Final Analysis

Page 1 / 1 100%
Loading...